Waddell & Associates, LLC Biogen Inc. Transaction History

Waddell & Associates, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$222.59 - $267.94 $10,906 - $13,129	-49 Reduced 5.52%	838 $216,000
Q1 2023 May 10, 2023	SELL	$256.56 - $292.34 $1,539 - $1,754	-6 Reduced 0.67%	887 $246,000
Q4 2022 Feb 09, 2023	BUY	$252.44 - $306.72 $1,514 - $1,840	6 Added 0.68%	893 $247,000
Q3 2022 Nov 02, 2022	BUY	$194.69 - $268.46 $172,690 - $238,124	887 New	887 $237,000
Q1 2022 Apr 21, 2022	SELL	$193.77 - $244.14 $171,873 - $216,552	-887 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$259.0 - $414.71 $229,733 - $367,847	887 New	887 $307,000

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Waddell & Associates, LLC, based on Form 13F filings with the SEC.

Stay updated on Waddell & Associates, LLC with notifications on news.